Australian Federal Court has upheld Pfizer’s Australian Patent AU 601,981 (the ‘981 patent) covering atorvastatin, the active ingredient in Lipitor, blocking Ranbaxy from launching its generic version before May 2012. However, Justice Neil Young in his judgment also revoked Australian Patent AU 628,198 (the ‘198 patent) covering calcium salt of atorvastatin. Pfizer in its statement said it would appeal the decision to revoke the ‘198 patent.
No comments:
Post a Comment